A Research Dynamo: Avi Schroeder at Technion Israel Institute of Technology

A Research Dynamo: Avi Schroeder at Technion Israel Institute of Technology

43-year-old Technion research dynamo Avi Schroeder is on a mission—and a “phenomenon” with four startup ventures under his belt, he works furiously and relentlessly to identify a cure for cancer from elephant protein to personalizing chemotherapy. The Yeshiva graduate...
Jun Zhu, MD, PhD  with Beijing University Cancer Hospital Principal Investigator for Brukinsa

Jun Zhu, MD, PhD with Beijing University Cancer Hospital Principal Investigator for Brukinsa

Recently, BeiGene Ltd’s lymphoma treatment Brukinsa was approved by the U.S. Food and Drug Administration. This is the first time a drug developed predominantly in China by a Chinese biopharma sponsor has been approved within America. The key clinical trials...
Dr. Lyudmila Bazhenova, MD & Immuno-Oncology Clinical Investigator Discusses Adverse Events

Dr. Lyudmila Bazhenova, MD & Immuno-Oncology Clinical Investigator Discusses Adverse Events

Dr. Lyudmila Bazhenova, professor of Medicine and thoracic oncologist with the University of California San Diego, and active principal investigator in advanced immunotherapy-based clinical trials, highlights immunotherapy-related adverse events (AEs) for the Oncology...

Pin It on Pinterest